Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Topics in Antiviral Medicine|April 19, 2013
Impact of new therapeutics for hepatitis C virus infection in incarcerated populationsAnne S Spaulding, Arthur Y Kim, Amy Jo Harzke, et al.
Addiction (Abingdon, England)|March 22, 2022
Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysisAlexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, et al.
The Journal of School Health|March 7, 2022
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021Stephanie S Lee, Michelle Weitz, Kristin Ardlie, et al.
JMIR Public Health and Surveillance|January 22, 2019
Applying National Estimates of Adults With Indications for Pre-Exposure Prophylaxis to Populations of Men Who Have Sex With Men and People Who Inject Drugs in Colorado: Modeling StudyJennifer A Donnelly, Thomas T Deem, Megan A Duffy, et al.
AIDS Patient Care and Stds|June 7, 2021
HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department PatientsJason S Haukoos, Douglas A E White, Sarah E Rowan, et al.
Open Forum Infectious Diseases|July 26, 2019
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP CareKevin F Kamis, Grace E Marx, Kenneth A Scott, et al.
The American Journal of Emergency Medicine|October 14, 2021
Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxisJason S Haukoos, Douglas A E White, Sarah E Rowan, et al.
Drug and Alcohol Dependence|October 29, 2022
Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2021
Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling StudyJoshua A Barocas, Alexandra Savinkina, Sara Lodi, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2024
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United StatesChristina E Freibott, Ali Jalali, Sean M Murphy, et al.
Pageof 22